CopyMark Law Group
4.9/5
Drawing for AVVIO

USPTO serial 98542854

AVVIO

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
WILLIS, PAMELA Y
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with AVVIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $300

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marjorie Witter Norman

Marjorie Witter Norman Reed Smith LLP1901 Avenue of the Stars, Suite 700Los Angeles, CA 90067United States

Goods and services

ClassDescriptionStatusFirst use
010Medical devices for treatment of urolithiasis and nephrolithiasis; medical apparatus and instruments for treatment of urolithiasis and nephrolithiasis; medical devices for treating urological conditions; medical devices for eliminating kidney stones; medical devices for kidney stone treatment and removal; medical ultrasound devices for eliminating kidney stones; lithotripsy device for treating urological conditions; kidney stone treatment procedure kits consisting of ureteral catheters; low pressure external ultrasound for lithiasis; ureteral beacon catheters; handheld ultrasound devices for treating urological conditions; medical apparatus and instruments for treating urological conditionsACTIVE—
042Providing medical and scientific research information via a website; providing medical and scientific research information via a website in the field of urology; providing information for medical professionals and medical patients concerning research and development of kidney stone removal equipment by means of a website; medical research and development in the field of urology; research, development, and design services in the field of medical devices; research, development, and design services in the field of medical devices for urological conditions; development and design of medical devices for urological conditions; providing medical and scientific information on clinical studies via a website; providing medical and scientific information on clinical studies on urological conditions via a websiteACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 25, 2026EX3GSOU EXTENSION 3 GRANTED—
Sep 25, 2026EXT3SOU EXTENSION 3 FILED—
Sep 25, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 22, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 22, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 22, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 26, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 25, 2026EX2GSOU EXTENSION 2 GRANTED—
Mar 25, 2026EXT2SOU EXTENSION 2 FILED—
Mar 25, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 19, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 18, 2025EX1GSOU EXTENSION 1 GRANTED—
Sep 18, 2025EXT1SOU EXTENSION 1 FILED—
Sep 18, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 25, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 28, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 28, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 4, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 23, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Dec 23, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 23, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 23, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 18, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 18, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 18, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 16, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 16, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 16, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 23, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 23, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 23, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 23, 2024DOCKASSIGNED TO EXAMINER—
Oct 30, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 9, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 9, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance